首页> 外文期刊>Pain medicine : >Refractory chronic pain screening tool (RCPST): A feasibility study to assess practicality and validity of identifying potential neurostimulation candidates
【24h】

Refractory chronic pain screening tool (RCPST): A feasibility study to assess practicality and validity of identifying potential neurostimulation candidates

机译:难治性慢性疼痛筛查工具(RCPST):一项可行性研究,用于评估识别潜在神经刺激候选者的实用性和有效性

获取原文
获取原文并翻译 | 示例
       

摘要

Objective: An international panel of pain specialists (anesthesiology, neurology, neurosurgery, and psychology) and research methodologists developed a screening tool to identify patients who may be suitable for spinal cord stimulation (SCS)-the Refractory Chronic Pain Screening Tool (RCPST) prototype. We describe a feasibility study to explore practicality and validity of this prototype. Design: Consecutive outpatients were screened in two centers (United Kingdom and United States). Sixty chronic pain adults without satisfactory pain relief despite treatment were assessed using RCPST (by pain specialist without expertise in neurostimulation) and then evaluated by two pain specialists experienced in SCS implantation and management to determine whether the patient should be referred for SCS. To maintain blinding, the participating physicians did not inform each other or the patient of assessment outcome. Sensitivity and specificity of the RCPST prototype were calculated using implanters' judgment as "gold standard." Results: The average age of patients was 47.7 years; 53% were female. Fifty-seven patients completed the study (one withdrew consent, two lost to follow-up). The pain specialists agreed the prototype was easy to use and took <10 minutes to complete. Implanter agreement was moderate (Kappa: 0.63, 95% confidence interval: 0.35-0.91). The prototype had low sensitivity (40%, 19-61%) and moderate specificity (78%, 65-92%). Using the same questionnaire with a modified decision algorithm, new prototypes were generated with range of high sensitivity (80-100%) and specificity (89-97%) values. Conclusions: The RCPST aims to identify patients that should be referred for consideration for neurostimulation. The final implant decision requires appropriate neurological diagnostic workup, psychological assessment, and trial stimulation. RCPST was considered practical for routine clinical practice and contained appropriate questions. Sensitivity needs to be improved. A future study should select and validate the ideal RCPST prototype.
机译:目的:国际疼痛专家小组(麻醉学,神经病学,神经外科和心理学)和研究方法学家开发了一种筛查工具,以鉴定可能适合进行脊髓刺激(SCS)的患者-难治性慢性疼痛筛查工具(RCPST)原型。我们描述了可行性研究,以探索该原型的实用性和有效性。设计:在两个中心(英国和美国)对连续的门诊病人进行筛查。使用RCPST(无神经刺激专业知识的疼痛专家)评估了六十名尽管治疗仍没有令人满意的缓解疼痛的慢性疼痛成年人,然后由两名在SCS植入和治疗方面经验丰富的疼痛专家评估,以确定是否应将患者转诊至SCS。为了保持盲目性,参与研究的医生没有相互告知患者或评估结果。 RCPST原型的敏感性和特异性是使用植入者的判断作为“金标准”来计算的。结果:患者的平均年龄为47.7岁。 53%是女性。 57位患者完成了研究(1位撤回同意,2位失去随访)。疼痛专家认为该原型易于使用,并且只需不到10分钟即可完成。植入器协议适度(Kappa:0.63,95%置信区间:0.35-0.91)。该原型的灵敏度低(40%,19-61%),特异性中等(78%,65-92%)。使用具有改进决策算法的相同调查表,可以生成具有高灵敏度(80-100%)和特异性(89-97%)值范围的新原型。结论:RCPST旨在确定应转介考虑进行神经刺激的患者。最终的植入决定需要适当的神经系统诊断检查,心理评估和试验刺激。 RCPST被认为可用于常规临床实践,并包含适当的问题。灵敏度需要提高。未来的研究应选择并验证理想的RCPST原型。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号